However, the CTNNAL1 plus ILK 2-gene signature could predict poor overall survival of NSCLC patients (hazard ratio [HR] = 1.6, log-rank P = 0.046) (Figure 6H). This evidence concerns the gene CTNNAL1 and non-small cell lung carcinoma.